Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Brain Res ; 233(2): 359-67, 1982 Feb 11.
Article in English | MEDLINE | ID: mdl-7059814

ABSTRACT

High affinity choline uptake (HACU) and choline acetyltransferase (CAT) were measured in the cerebral cortex of rats 4 and 20 days after placing electrolytic lesions in the magnocellular forebrain nuclei (MFN) or in the pallidum. Four days after MFN lesion a 40-50% decrease in ipsilateral cortical HACU was found and a slightly smaller decrease was found 4 days after the pallidum lesion. Twenty days after the lesion, HACU activity returned to control values in the ipsilateral parietal cortex, its decrease was smaller than 4 days postlesion in the ipsilateral frontal cortex and a significant increase was found in the contralateral cortex. CAT activity showed a 40% decrease in the frontal, parietal and occipital ipsilateral cortex 4 days after MFN lesion. The same decrease was found 20 days postlesion. However, at this time a significant increase in CAT activity was detected in the contralateral cortex. The ipsilateral recovery of HACU activity 20 days after the lesions and the contralateral increase in HACU and CAT activity demonstrate the remarkable and widespread functional adjustment associated with discrete brain lesions. The existence of a large cholinergic pathway projecting to the neocortex from the basal forebrain region is also confirmed.


Subject(s)
Cerebral Cortex/enzymology , Choline/metabolism , Globus Pallidus/physiology , Hypothalamus/physiology , Preoptic Area/physiology , Animals , Choline O-Acetyltransferase/metabolism , Dominance, Cerebral/physiology , Frontal Lobe/enzymology , Male , Neural Pathways/physiology , Occipital Lobe/enzymology , Parietal Lobe/enzymology , Rats , Rats, Inbred Strains
2.
Eur J Pharmacol ; 40(2): 329-35, 1976 Dec.
Article in English | MEDLINE | ID: mdl-991939

ABSTRACT

Acetylcholine (ACh) levels were determined in the brain of rats killed by decapitation or focussed microwave radiation during drug-induced convulsions. During metrazol or strychnine-induced convulsions a diffuse decrease in ACh levels was found in rats killed by decapitation. When the rats were killed by radiation and the brain was only divided into three large regions, strychnine caused no changes in ACh levels; metrazol caused a decrease in the cerebral cortex and lower brainstem. When discrete brain regions were investigated in rats killed by radiation, metrazol-induced convulsions were associated with a decrease in ACh level in all regions dissected and strychnine-induced convulsions with a decrease in the hippocampus and caudate nucleus only. Picrotoxin-induced convulsions were associated with a decrease in ACh level in the cerebral cortex, hippocampus, midbrain and medulla-pons, those induced by bicuculline with an increase in ACh level in the frontal cortex, hippocampus, midbrain and medulla-pons, by dimefline with an increase in the frontal cortex, midbrain and medulla-pons and a decrease in the caudate nucleus. The experiments show that each type of convulsant affects ACh levels in discrete brain regions in a different way.


Subject(s)
Acetylcholine/analysis , Brain Chemistry/drug effects , Seizures/metabolism , Animals , Bicuculline/pharmacology , Male , Pentylenetetrazole/pharmacology , Picrotoxin/pharmacology , Rats , Seizures/chemically induced , Strychnine/pharmacology
3.
Article in English | MEDLINE | ID: mdl-2879319

ABSTRACT

A review of the work on the neurochemical, electroencephalographic and behavioral changes induced in the rat by lesions of the nucleus basalis is presented. The similarities and differences between the effects of the lesions and the neurochemical and clinical alterations characterizing senile dementia of Alzheimer type are pointed out. The decrease in choline acetyltransferase (ChAT) activity in the cortex following unilateral or bilateral electrolytic or neurotoxic lesions of the nucleus basalis are described and compared with the decrease in ChAT activity found in the cortex and hippocampus of patients affected by senile dementia. At variance with the latter condition, in rats with lesions of the nucleus basalis a spontaneous recovery in cortical ChAT activity has been observed 3-6 months after the lesion. The lesions of the nucleus basalis decrease high affinity choline uptake activity which, however, undergoes a rapid recovery. Lesions also decrease spontaneous and drug-stimulated ACh release from the cerebral cortex. Transitory changes in the number of muscarinic binding sites have been reported in the cerebral cortex of the lesioned rats while a decrease in the number of muscarinic binding sites has generally been found in the cerebral cortex of patients with senile dementia. [3H] glutamate uptake in the striatum of the lesioned rats was not affected. In both lesioned rats and patients affected by senile dementia, a decrease of low voltage high frequency electrocortical activity has been reported. Unilateral and bilateral lesions of the nucleus basalis bring about an impairment of the acquisition of active and passive avoidance responses and of the rewarded alternation discriminatory tasks involving working memory and spatial memory. On the other hand, memory impairment is a typical symptom of senile dementia. In conclusion, the lesions of the nucleus basalis only partly mimic the complex clinical picture of senile dementia of Alzheimer type. They offer, nevertheless, a useful tool for understanding the critical role of the central cholinergic pathways in some of the cognitive processes and identifying potentially useful pharmacological treatments.


Subject(s)
Alzheimer Disease/etiology , Basal Ganglia/physiology , Disease Models, Animal , Substantia Innominata/physiology , Animals , Behavior, Animal , Choline/metabolism , Choline O-Acetyltransferase/analysis , Glutamates/metabolism , Glutamic Acid , Rats , Receptors, Muscarinic/analysis
4.
J Neural Transm Suppl ; 44: 189-94, 1994.
Article in English | MEDLINE | ID: mdl-7897390

ABSTRACT

In order to establish how closely the models mimic aging and Alzheimer's disease, a comparison was made, using the extensive literature available, between brain cholinergic dysfunction in aging animals and man, and between that in animals with lesions of the nucleus basalis of Meynert and in subjects affected by Alzheimer's disease. It is concluded that cholinergic dysfunction in the aging rat closely resembles that in aging man. A similarity can also be found between the cortical dysfunction induced by lesions of the nucleus basalis and that occurring in patients with Alzheimer's disease. However, cholinergic dysfunction only represents a limited aspect of the neorotransmitter deficits and neuropathological alterations of the disease.


Subject(s)
Acetylcholine/metabolism , Aging/physiology , Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Prosencephalon/physiology , Substantia Innominata/physiology , Acetylcholinesterase/metabolism , Animals , Choline O-Acetyltransferase/metabolism , Humans , Neurons/physiology , Prosencephalon/growth & development , Prosencephalon/pathology , Rats , Receptors, Muscarinic/metabolism , Receptors, Nicotinic/metabolism , Substantia Innominata/growth & development , Substantia Innominata/pathology
5.
Pharmacol Biochem Behav ; 17(5): 933-7, 1982 Nov.
Article in English | MEDLINE | ID: mdl-6294688

ABSTRACT

The acquisition of active (shuttle-box) and passive avoidance conditioned responses and the effects of scopolamine on acetylcholine (ACh) output in freely moving rats and on conditioned responses were investigated 20 days after placing a unilateral lesion in the magnocellular forebrain nuclei (MFN). In the lesioned rats spontaneous ACh output from the cerebral cortex ipsilateral to the lesion was slightly decreased, while on the other hand the increase in ACh output elicited by scopolamine was strongly reduced. Sham operated rats always performed more active avoidance responses than MFN lesioned rats in the daily training shuttle-box sessions, and the facilitating effect of scopolamine (1 mg/kg IP) on the shuttle-box performance was suppressed. However the lesion did not disrupt the shuttle-box performance whenever training had taken place before the lesion. In the lesioned rats retested 30 min after the training trial, an impairment of the passive avoidance response was found. The effect of the lesion was potentiated by scopolamine. The results show therefore that MFN lesions impair the cortical cholinergic mechanisms, whose activity seems to play an important role in cognitive functions.


Subject(s)
Avoidance Learning/physiology , Cerebral Cortex/physiology , Globus Pallidus/physiology , Preoptic Area/physiology , Receptors, Cholinergic/physiology , Scopolamine/pharmacology , Animals , Avoidance Learning/drug effects , Cerebral Cortex/drug effects , Globus Pallidus/drug effects , Male , Neural Pathways/drug effects , Neural Pathways/physiology , Preoptic Area/drug effects , Rats , Rats, Inbred Strains , Receptors, Cholinergic/drug effects , Retention, Psychology/physiology , Synaptic Transmission/drug effects
9.
J Reprod Fertil Suppl ; 46: 155-62, 1993.
Article in English | MEDLINE | ID: mdl-8315616

ABSTRACT

The complex picture of age-associated brain cholinergic deficiency in humans and animals, and the possibilities of correcting it, are presented in this article. The changes that occur during ageing and senile dementias in cholinergic neurones and receptors and in the release and synthesis of acetylcholine are described and discussed. The drugs that have so far been administered to humans to correct cholinergic deficiency are listed and the effects of cholinesterase inhibitors, nerve growth factor and phosphatidylserine are discussed in some detail.


Subject(s)
Acetylcholine/metabolism , Aging/metabolism , Brain/metabolism , Mammals/metabolism , Receptors, Cholinergic/metabolism , Aged , Alzheimer Disease/metabolism , Animals , Humans
10.
Drug Des Deliv ; 7(1): 1-10, 1990 Dec.
Article in English | MEDLINE | ID: mdl-2096830

ABSTRACT

The search for drugs of use in the treatment of age-associated memory impairment, multi-infarct dementia, and Alzheimer's disease is frustrated by the expense or inadequacy of animal models of these conditions. We hope that this critical review of existing models will stimulate the use and proper interpretation of the best of these models, and encourage thinking in devising new models.


Subject(s)
Aging/physiology , Brain/drug effects , Disease Models, Animal , Alzheimer Disease/physiopathology , Animals , Brain/physiology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL